Delivery Order SPE2DB20D3101-SPE2DB25FRVM5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,378.26 to AmerisourceBergen Drug Corp for WIXELA 500-50 inhalers (60-count) on September 2, 2025, with ultimate completion by September 3, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a small-value transaction typical of routine pharmaceutical supply replenishment orders. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work from its...
- The Defense Logistics Agency awarded a delivery order valued at $2,022.88 to AmerisourceBergen Drug Corp for WIXELA 250-50 inhalation powder (60 doses), a combination pharmaceutical product, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed on August 27, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,483.86 to AmerisourceBergen Drug Corp for WIXELA 100-50 inhalation powder, a combination asthma and COPD medication. Issued on August 5, 2025, with an ultimate completion date of August 6, 2025, this firm fixed-price delivery order was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order valued at $1,271.67 to AmerisourceBergen Drug Corp for Wixela 250-50 inhaler (60-count), a combination pharmaceutical product. The contract, executed on September 11, 2025, with an ultimate completion date of September 12, 2025, operates under firm fixed-price terms with no set-aside designation, indicating competitive award. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,496.16 to AmerisourceBergen Drug Corp on September 3, 2025, for WIXELA 250-50 inhaler units (60-count). This is a firm fixed price, non-set-aside contract with a completion date of September 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $1,378.26 to AmerisourceBergen Drug Corp for WIXELA 500-50 inhaler units (60-count) on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The award was made without a set-aside designation, and performance will take place at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $2,374.92 to AmerisourceBergen Drug Corp for WIXELA 250-50 inhalers (60-count), with an ultimate completion date of August 29, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and represents a direct fulfillment of pharmaceutical supply needs through AmerisourceBergen's existing contract vehicle. The product will be delivered to the vendor's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for WIXELA 250-50 inhalation powder (60-unit package) with a ceiling value of $1,733.01. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a $10,386.94 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Wixela 250-50 inhalers (60-count units). This is a firm fixed price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania facility and an ultimate completion date of September 11, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,548.77 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the pharmaceutical product Wixela 250-50 inhaler with 60 doses. The contract represents a non-competitive, non-set-aside delivery order with an ultimate completion date of September 3, 2025, and is to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRVM5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,500.48 to AmerisourceBergen Drug Corp for Wixela 250-50 inhalation powder, a combination maintenance medication used to treat chronic obstructive pulmonary disease. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the awardee and place of performance for this delivery order. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, positioning AmerisourceBergen as a critical vendor in the federal medical procurement supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/13/25 |